SCHEMBL8950331

SCHEMBL8950331

CC(C)N1C(CN2CCOCC2)=Cc2cc(S(N)(=O)=O)sc2S1(=O)=O

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 20/20 0.62
CA4 P22748 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950571 0.86 CA2 (0.65) CA2CA4
SCHEMBL8950166 0.86 CA2 (0.60) CA2CA4
Hydrochloric Acid SCHEMBL8950440 0.85 CA2 (0.64) CA2CA4
SCHEMBL8950259 0.84 CA2 (0.63) CA2CA4
Hydrochloric Acid SCHEMBL8950323 0.84 CA2 (0.62) CA2CA4
SCHEMBL8950408 0.84 CA2 (0.62) CA2CA4
Hydrochloric Acid SCHEMBL8950254 0.83 CA2 (0.61) CA2CA4
SCHEMBL8950256 0.82 CA2 (0.64) CA2CA4
SCHEMBL8950332 0.80 CA2 (0.43) CA2CA4
SCHEMBL8950278 0.80 CA2 (0.75) CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US claimed
US-5538966-A ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1996-07-23 US disclosed